Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2017 | 1 |
2020 | 2 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Showing results for
vancomycin actavis
Your search for
vancomicina-actavis
retrieved no results
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal beta-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
JAMA. 2020 Feb 11;323(6):527-537. doi: 10.1001/jama.2020.0103.
JAMA. 2020.
PMID: 32044943
Free PMC article.
Clinical Trial.
INTERVENTIONS: Participants were randomized to standard therapy (intravenous vancomycin or daptomycin) plus an antistaphylococcal beta-lactam (intravenous flucloxacillin, cloxacillin, or cefazolin) (n = 174) or standard therapy alone (n = 178). ...CONCLUSIONS AND RELEVANCE …
INTERVENTIONS: Participants were randomized to standard therapy (intravenous vancomycin or daptomycin) plus an antistaphylococcal bet …
Genomic Epidemiology of Vancomycin-Resistant Enterococcus faecium (VREfm) in Latin America: Revisiting The Global VRE Population Structure.
Rios R, Reyes J, Carvajal LP, Rincon S, Panesso D, Echeverri AM, Dinh A, Kolokotronis SO, Narechania A, Tran TT, Munita JM, Murray BE, Planet PJ, Arias CA, Diaz L.
Rios R, et al.
Sci Rep. 2020 Mar 27;10(1):5636. doi: 10.1038/s41598-020-62371-7.
Sci Rep. 2020.
PMID: 32221315
Free PMC article.
Little is known about the population structure of vancomycin-resistant Enterococcus faecium (VREfm) in Latin America (LATAM). ...
Little is known about the population structure of vancomycin-resistant Enterococcus faecium (VREfm) in Latin America (LATAM). ...
Item in Clipboard
A Reference Broth Microdilution Method for Dalbavancin In Vitro Susceptibility Testing of Bacteria that Grow Aerobically.
Koeth LM, DiFranco-Fisher JM, McCurdy S.
Koeth LM, et al.
J Vis Exp. 2015 Sep 9;(103):53028. doi: 10.3791/53028.
J Vis Exp. 2015.
PMID: 26381422
Free PMC article.
Dalbavancin has activity against Staphylococcus aureus (including both methicillin-susceptible S. aureus [MSSA] and methicillin-resistant S. aureus [MRSA]), coagulase-negative staphylococci, Streptococcus pneumoniae, Streptococcus anginosus group, beta-hemolytic streptococci and …
Dalbavancin has activity against Staphylococcus aureus (including both methicillin-susceptible S. aureus [MSSA] and methicillin-resistant S. …
Item in Clipboard
Update of the activity of telavancin against a global collection of Staphylococcus aureus causing bacteremia, including endocarditis (2011-2014).
Mendes RE, Sader HS, Smart JI, Castanheira M, Flamm RK.
Mendes RE, et al.
Eur J Clin Microbiol Infect Dis. 2017 Jun;36(6):1013-1017. doi: 10.1007/s10096-016-2865-8. Epub 2017 Jan 22.
Eur J Clin Microbiol Infect Dis. 2017.
PMID: 28111724
Free PMC article.
Similar telavancin activities (MIC(50), 0.03 mug/ml) were observed against MRSA subsets from North America and Europe, while isolates from the Asia-Pacific (APAC) and Latin America regions had MIC(50) values of 0.06 mug/ml. MRSA with vancomycin MIC values of 2-4 mug/ml and …
Similar telavancin activities (MIC(50), 0.03 mug/ml) were observed against MRSA subsets from North America and Europe, while isolates from t …
Item in Clipboard
Cite
Cite